Literature DB >> 3170112

Primary glomerulonephritis in Hong Kong.

M K Chan1, P D Yin, K W Chan.   

Abstract

The clinical presentation and natural history of 428 patients with biopsy-proven primary glomerulonephritis were reviewed. Minimal change glomerulonephritis presented with the nephrotic syndrome and followed a benign course. Membranous glomerulonephritis took a slow downhill course. HBs antigenaemia was present in 30% of patients with membranous glomerulonephritis. Mesangiocapillary glomerulonephritis often presented with mixed nephritic-nephrotic syndrome and had a bad prognosis. No type II variant was detected. Mesangial IgA glomerulonephritis commonly presented with abnormal urinary sediments although 2.5% of adults presenting with the nephrotic syndrome without glomerular insufficiency had mesangial IgA disease. Mesangial IgA glomerulonephritis was an important cause of end-stage renal failure in Hong Kong.

Entities:  

Mesh:

Year:  1988        PMID: 3170112     DOI: 10.1007/bf02549575

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  2 in total

1.  Combined report on regular dialysis and transplantation in Europe, VIII, 1977.

Authors:  A J Wing; F P Brunner; H Brynger; C Chantler; R A Donckerwolcke; H J Gurland; R A Hathway; C Jacobs; N H Selwood
Journal:  Proc Eur Dial Transplant Assoc       Date:  1978

2.  Hepatitis B induced glomerulonephritis, fact or fiction?

Authors:  M K Sham; K K Pun; C K Yeung; W L Ng; W K Chang; M K Chan
Journal:  Aust N Z J Med       Date:  1985-06
  2 in total
  2 in total

1.  Focal sclerosing glomerulopathy. Risk factors of progression and optimal mode of treatment.

Authors:  P C Chan; K W Chan; I K Cheng; M K Chan
Journal:  Int Urol Nephrol       Date:  1991       Impact factor: 2.370

2.  Clinical outcomes and predictors for ESRD and mortality in primary GN.

Authors:  Yu-Hsiang Chou; Yu-Chung Lien; Fu-Chang Hu; Wei-Chou Lin; Chih-Chin Kao; Chun-Fu Lai; Wen-Chih Chiang; Shuei-Liong Lin; Tun-Jun Tsai; Kwan-Dun Wu; Yung-Ming Chen
Journal:  Clin J Am Soc Nephrol       Date:  2012-07-12       Impact factor: 8.237

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.